Lisata Therapeutics, Inc. Financial Ratios — LSTA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-86.32	-114.07	-81.45	-90.66	-196.74	-228.39	82.97	-36.65	-66.14	-30.57	-44.03	-68.28	-36.33	-51.43	-74.67
Return on Assets (%)	-31.6	-51.27	-54.06	-50.79	-88.17	-58.99	39.32	-29.95	-53.98	-25.81	-41.3	-63.78	-32.63	-44.56	-62.89
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	13.96	16.61	11.73	12.6	10.36	- -	- -	- -	- -	- -	- -	- -	- -	100	100
EBITDA Margin (%)	-324.02	-201.22	-239.99	-309.69	-217.41	- -	- -	- -	- -	- -	- -	- -	- -	-2,223.5	-10,625.29
Operating Margin (%)	-338.35	-212.04	-250.94	-321.88	-229.35	- -	- -	- -	- -	- -	- -	- -	- -	-2,240.9	-10,711.18
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	-98.16	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-343.94	-253.15	-263.87	-309.78	-436.93	- -	- -	- -	- -	- -	- -	- -	- -	-2,078.3	-10,322.35
Profit Margin (%)	-469	-375.23	-265.75	-305.89	-359.69	- -	- -	- -	- -	- -	- -	- -	- -	-1,998.5	-9,756.47
Net Income to Common Margin (%)	-475.37	-378.91	-265.75	-305.89	-359.69	- -	- -	- -	- -	- -	- -	- -	- -	-1,998.5	-9,756.47
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	1.43	0.41	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-85.09	-113.6	-81.45	-90.66	-196.74	-228.39	82.97	-36.65	-66.14	-30.57	-44.03	-68.28	-36.33	-51.43	-74.67

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	4	4	17	17	8	- -	- -	1	1	1	- -	- -	- -	- -
ST Debt	4	4	1	2	5	5	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	4	15	11	3	- -	- -	1	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.12	-0.13	-0.12	-0.3	-0.34	-0.28	-0.01	- -	-0.05	-0.03	-0.02	-0.01	-0.01	-0.01	- -
Net Debt/EBITDA	- -	0.34	1.19	0.05	0.07	-0.03	1.07	0.61	0.7	0.87	0.85	0.56	0.89	0.73	0.88
Total Debt/EBIT	-0.11	-0.13	-0.11	-0.29	-0.33	-0.27	-0.01	- -	-0.05	-0.03	-0.02	-0.01	-0.01	-0.01	- -
Net Debt/EBIT	- -	0.33	1.14	0.04	0.07	-0.03	1.05	0.61	0.7	0.86	0.85	0.56	0.88	0.72	0.88
EBITDA to Interest Expense	-12.3	-18.29	-125.09	-73.51	-22.97	-16.32	-72.01	-3,352.4	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-12.52	-18.62	-134.66	-78.35	-24.47	-16.94	-72.37	-3,379.2	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-12.84	-19.27	-130.8	-76.41	-24.23	-16.58	-73	-3,397.4	- -	- -	- -	- -	- -	- -	- -
Interest Expense	3	2	- -	1	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	39.93	60.98	69.63	46.34	41.45	9.13	79.69	84.63	76.66	90.26	95.1	91.16	88.03	84.48	83.72
Long-Term Debt/Equity (%)	- -	0.52	5.73	25.34	49.01	66	- -	- -	3.04	0.79	0.53	0.46	- -	- -	- -
Long-Term Debt/Capital (%)	- -	0.47	5.37	19.7	28.49	22.14	- -	- -	2.9	0.77	0.52	0.46	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	0.32	3.96	11.65	19.95	5.02	- -	- -	2.3	0.71	0.5	0.42	- -	- -	- -
Total Debt/Equity (%)	4.72	11.62	6.69	28.66	72.05	198.11	0.32	- -	4.76	1.94	0.78	0.73	0.35	0.47	- -
Total Debt/Capital (%)	4.51	10.41	6.27	22.27	41.88	66.45	0.32	- -	4.54	1.9	0.77	0.73	0.35	0.47	- -
Total Debt/Total Assets (%)	2.44	7.01	4.62	13.18	29.33	15.05	0.25	- -	3.6	1.73	0.74	0.66	0.31	0.39	- -
Net Debt to Equity	-0.19	-30.24	-67.69	-4.36	-15.22	24.08	-57.79	-27.5	-68.27	-51.21	-26.79	-48.48	-47.17	-55.29	-109.28
Net Debt/Capital (%)	-0.19	-43.35	-209.49	-4.56	-17.95	19.41	-136.91	-37.93	-187.12	-100.97	-36.21	-92.78	-88.71	-122.38	1,177.56
EBITDA	-33	-29	-35	-56	-49	-29	-27	-17	-20	-19	-29	-58	-26	-22	-18
EBITDA-CapEx	-33	-29	-38	-59	-52	-30	-27	-17	-20	-19	-29	-58	-26	-22	-18
Operating Income (Loss)	-34	-30	-37	-58	-52	-30	-28	-17	-20	-19	-29	-58	-26	-22	-18

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.11	1.38	4.7	1.62	0.97	0.33	5.91	7.66	4.21	9.86	21	10.85	7.67	5.57	5.2
Current Ratio	1.06	1.68	5.18	2.23	1.39	1.16	6.59	7.85	4.35	10.08	21.27	11.26	8.18	6.16	5.76
Quick Ratio	0.14	1.49	4.89	1.81	1.09	0.34	5.94	7.66	4.21	9.86	21	10.85	7.67	5.73	5.2
CFO/Avg Current Liab	-0.6	-0.6	-2.74	-3.6	-2.11	-1.12	-1.37	-2.68	-3.26	-1.86	-5.54	-3.88	-3.09	-3.17	-3.67
Common Equity/Total Assets	39.93	60.98	69.63	46.34	41.45	9.13	79.69	84.63	76.66	90.26	95.1	91.16	88.03	84.48	83.72
Long-Term Debt/Equity (%)	- -	0.52	5.73	25.34	49.01	66	- -	- -	3.04	0.79	0.53	0.46	- -	- -	- -
Long-Term Debt/Capital (%)	- -	0.47	5.37	19.7	28.49	22.14	- -	- -	2.9	0.77	0.52	0.46	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	0.32	3.96	11.65	19.95	5.02	- -	- -	2.3	0.71	0.5	0.42	- -	- -	- -
Total Debt/Equity (%)	4.72	11.62	6.69	28.66	72.05	198.11	0.32	- -	4.76	1.94	0.78	0.73	0.35	0.47	- -
Total Debt/Capital (%)	4.51	10.41	6.27	22.27	41.88	66.45	0.32	- -	4.54	1.9	0.77	0.73	0.35	0.47	- -
Total Debt/Total Assets (%)	2.44	7.01	4.62	13.18	29.33	15.05	0.25	- -	3.6	1.73	0.74	0.66	0.31	0.39	- -
CFO/Total Liabilities	-27.83	-64.17	-97.52	-68.76	-115.73	-47.86	-158.31	-280.47	-286.09	-234.65	-444.19	-315.5	-294.59	-340.47	-507.45
CFO/CapEx	-36.41	-26.07	-10.07	-12.82	-12.32	-21.53	-154.64	-149.15	- -	-441.15	-370.75	-74.28	- -	- -	-569.61
Altman's Z-Score	-1.88	-9.56	-1.99	-9.18	-12.84	-14.65	-7.37	-9.76	-20.68	-12.82	-0.38	-9.51	-12.13	-20.49	-43.8

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	2.92	13.89	10.07	7.22	7.92	- -	- -	- -	- -	- -	- -	- -	- -	2.22	0.38
Days Sales Outstanding	124.97	26.29	36.26	50.58	46.08	- -	- -	- -	- -	- -	- -	- -	- -	164.25	966.18
Inventory Turnover	0.8	13.57	10.87	24.69	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	457.4	26.89	33.59	14.79	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	-1.42	5.13	4.43	3.2	4.13	9.83	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	-257.89	71.19	82.31	114.2	88.44	37.13	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	840.26	-18.01	-12.45	-48.83	-42.36	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-332.43	-0.61	2.67	35.8	46.08	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	9	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	-12	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	56	98	185	139	61	23	33	35	26	28	50	20	22	25	16
- Cash & Cash Equivalents	4	14	46	19	20	7	29	10	14	17	25	32	23	16	16
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	18	- -	-1	- -	- -	-1	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	4	4	17	17	8	- -	- -	1	1	1	- -	- -	- -	- -
Enterprise Value	74	88	143	129	57	23	-22	-8	2	-6	-44	-49	-28	-6	- -
Total Capital	84	37	66	75	40	12	50	37	22	33	93	67	48	29	15
Total Debt/Capital (%)	4.51	10.41	6.27	22.27	41.88	66.45	0.32	- -	4.54	1.9	0.77	0.73	0.35	0.47	- -
Total Debt / EV	0.05	0.04	0.03	0.13	0.29	0.34	-0.01	- -	0.49	-0.1	-0.02	-0.01	-0.01	-0.02	- -
EV/Sales	7.33	6.14	9.75	7.17	2.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.3
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	45	83	140	123	52	19	31	34	26	22	46	13	22	25	16
Diluted Enterprise Value	63	73	97	121	48	19	2	24	13	6	22	-19	-1	8	- -
EV per Share	1,011.34	805.82	788.59	524.51	151.5	42.75	- -	- -	2.83	- -	- -	- -	- -	- -	0.03
TTM Sales	10	14	15	18	22	- -	- -	- -	- -	- -	- -	- -	- -	1	- -
TTM EBITDA	-33	-29	-35	-56	-49	-29	-27	-17	-20	-19	-29	-58	-26	-22	-18
TTM Operating Income	-34	-30	-37	-58	-52	-30	-28	-17	-20	-19	-29	-58	-26	-22	-18
TTM Cash Flow to Firm	-18	-12	-27	-46	-38	-22	-21	-20	-19	-9	-22	-21	-20	-19	-16
TTM Free Cash Flow to Firm	-18	-12	-24	-42	-34	-21	-21	-20	-19	-9	-22	-21	-20	-19	-16

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.22	-6.23	-5.73	-2.86	-1.45	-0.82	-1.52	-1.74	-1.37	-2.51	-2.09	-0.63	-1.1	-1.28	-1.01
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	74	88	143	129	57	23	-22	-8	2	-6	-44	-49	-28	-6	- -
Low Price	645	450	750	462	151.5	39.75	39.45	45.75	30	15.75	12.15	2.36	1.95	2.19	1.81
EV/Sales	7.33	6.14	9.75	7.17	2.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.3
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	1.37	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-2.14	-1.48	-3.44	-3.58	-1.34	-1.1	1.63	-2.91	-1.64	-3.89	-2.98	-0.73	-1.17	-1.25	-1.29
Price/Earnings High	-3.89	-2.29	-5.2	-4.95	-2.55	-2.67	3.04	-6.98	-2.9	-6.9	-9.85	-1.63	-1.76	-1.6	-2.2
Price/Earnings Low	-0.8	-0.76	-2.63	-1.84	-0.61	-0.53	1.03	-1.83	-1.07	-1.99	-1.63	-0.23	-0.76	-0.91	-0.95
Price/Book Value	0.9	2.96	2.97	2.37	2.58	4.75	0.66	0.93	1.27	0.85	0.54	0.3	0.46	0.85	1.11
Price/Book Value Average	2.04	2.87	2.84	3.77	5.33	9.17	0.78	1.27	1.55	1.23	0.96	0.91	0.51	0.85	1.46
Price/Book Value High	3.7	4.44	4.3	5.21	10.19	22.32	1.46	3.05	2.75	2.17	3.17	2.03	0.77	1.09	2.5
Price/Book Value Low	0.76	1.48	2.17	1.94	2.42	4.45	0.49	0.8	1.01	0.63	0.52	0.28	0.33	0.62	1.08
Price/Tangible Book Value	1.56	12.96	4.94	-9.73	4.43	-5.23	0.66	0.93	1.27	0.85	0.54	0.3	0.46	0.85	1.11
Price/Tangible Book Value Average	3.53	12.55	4.74	-15.49	9.15	-10.09	0.78	1.27	1.55	1.23	0.96	0.91	0.51	0.86	1.46
Price/Tangible Book Value High	6.41	19.45	7.16	-21.39	17.49	-24.56	1.46	3.05	2.75	2.17	3.17	2.04	0.77	1.1	2.5
Price/Tangible Book Value Low	1.31	6.48	3.62	-7.95	4.15	-4.89	0.49	0.8	1.01	0.63	0.52	0.28	0.33	0.63	1.08
Price/Sales	4.5	5.8	9.53	6.88	2.33	- -	- -	- -	- -	- -	- -	- -	- -	24.82	95.05
Price/Sales Average	10.19	5.61	9.14	10.96	4.81	- -	- -	- -	- -	- -	- -	- -	- -	25.03	125.57
Price/Sales High	18.51	8.69	13.82	15.14	9.19	- -	- -	- -	- -	- -	- -	- -	- -	31.9	214.62
Price/Sales Low	3.79	2.9	6.99	5.62	2.18	- -	- -	- -	- -	- -	- -	- -	- -	18.24	92.49
Price/Cash Flow	-2.16	-6	-5.16	-2.63	-1.33	-0.78	-1.51	-1.73	-1.37	-2.5	-2.09	-0.62	-1.1	-1.28	-1.01
Price/Cash Flow Average	-4.9	-5.8	-4.94	-4.19	-2.76	-1.51	-1.8	-2.35	-1.68	-3.6	-3.67	-1.87	-1.22	-1.29	-1.34
Price/Cash Flow High	-8.89	-8.99	-7.48	-5.79	-5.26	-3.68	-3.35	-5.65	-2.97	-6.37	-12.16	-4.18	-1.83	-1.65	-2.29
Price/Cash Flow Low	-1.82	-3	-3.78	-2.15	-1.25	-0.73	-1.13	-1.48	-1.09	-1.84	-2.01	-0.58	-0.79	-0.94	-0.99
Price/Free Cash Flow Average	-5.03	-6.03	-5.49	-4.55	-3	-1.59	-1.81	-2.37	-1.68	-3.61	-3.68	-1.89	-1.22	-1.29	-1.34
Price/Free Cash Flow High	-9.14	-9.35	-8.3	-6.28	-5.73	-3.86	-3.37	-5.69	-2.97	-6.38	-12.19	-4.24	-1.83	-1.65	-2.29
Price/Free Cash Flow Low	-1.87	-3.12	-4.2	-2.33	-1.36	-0.77	-1.14	-1.49	-1.09	-1.84	-2.02	-0.59	-0.79	-0.94	-0.99
EV/Sales Average	14.37	5.92	9.23	12.15	5.45	- -	- -	- -	- -	- -	- -	- -	- -	8.94	32.34
EV/Sales High	24.63	9.57	15.44	16.83	10.57	- -	- -	- -	- -	- -	- -	- -	- -	15.88	122.9
EV/Sales Low	6.46	2.71	6.37	6.15	2.37	- -	- -	- -	- -	- -	- -	- -	- -	2.09	- -
EV/EBITDA Average	-4.43	-2.94	-3.84	-3.92	-2.51	-1.55	-0.38	-2.23	-0.95	-1.24	-2.21	-0.49	-0.08	-0.4	-0.3
EV/EBITDA High	-7.6	-4.75	-6.43	-5.44	-4.86	-3.76	-1.64	-6.23	-2.19	-2.85	-9.25	-1.79	-0.56	-0.71	-1.16
EV/EBITDA Low	-2	-1.35	-2.66	-1.99	-1.09	-0.75	0.16	-1.16	-0.39	-0.22	-0.84	0.23	0.27	-0.09	0.01
EV/EBIT Average	-4.25	-2.79	-3.68	-3.77	-2.38	-1.52	-0.37	-2.2	-0.94	-1.24	-2.21	-0.49	-0.08	-0.4	-0.3
EV/EBIT High	-7.28	-4.51	-6.15	-5.23	-4.61	-3.7	-1.61	-6.14	-2.19	-2.84	-9.23	-1.79	-0.55	-0.71	-1.15
EV/EBIT Low	-1.91	-1.28	-2.54	-1.91	-1.03	-0.74	0.16	-1.15	-0.39	-0.22	-0.83	0.23	0.26	-0.09	0.01
Last Price	765	900	1,023	565.5	162	42.45	52.65	53.4	37.65	21.45	12.6	2.53	2.73	2.98	1.86
High Price	3,150	1,350	1,483.5	1,243.5	639	199.5	116.85	174.75	81.6	54.6	73.35	17.1	4.53	3.83	4.2
Enterprise Value Average	144	85	135	218	123	45	10	37	19	24	64	28	2	9	5
Enterprise Value High	248	137	226	302	238	109	45	104	44	54	268	103	14	16	21
Enterprise Value Low	65	39	93	110	53	22	-4	20	8	4	24	-13	-7	2	- -

Shares Outstanding	- -	- -	- -	- -	- -	1	1	1	1	1	4	8	8	8	9
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	1	1	1	1	4	5	8	8	9
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	1	1	1	1	4	5	8	8	9
Revenue per Share	170.15	155.29	107.35	82.15	69.54	- -	- -	- -	- -	- -	- -	- -	- -	0.12	0.02
EBITDA per Share	-551.33	-312.48	-257.64	-254.4	-151.18	-66.55	-45.53	-25.95	-29.09	-18.54	-7.86	-11.11	-3.16	-2.67	-2.08
Operating Income per Share	-575.71	-329.28	-269.39	-264.41	-159.49	-67.58	-46.15	-26.3	-29.19	-18.6	-7.88	-11.12	-3.18	-2.69	-2.1
Basic EPS, GAAP	-808.84	-588.41	-285.29	-251.28	-250.12	-74.81	38.43	-25.03	-28.13	-7.92	-7.45	-10.47	-2.58	-2.4	-1.91
Basic EPS from Cont Ops	-585.23	-391.22	-288.98	-254	-250.51	-71.6	-27.04	-25.03	-28.11	-7.91	-7.45	-10.47	-2.58	-2.4	-1.91
Diluted EPS, GAAP	-808.84	-588.41	-285.29	-251.28	-250.12	-74.81	38.43	-25.03	-28.13	-7.92	-7.45	-10.47	-2.58	-2.4	-1.91
Diluted EPS from Cont Ops	-585.23	-391.22	-288.98	-254	-250.51	-71.6	-27.04	-25.03	-28.11	-7.91	-7.45	-10.47	-2.58	-2.4	-1.91
Dividend per Share	- -	3.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-354.32	-150.12	-198.35	-214.75	-121.4	-54.22	-34.91	-30.94	-27.43	-8.57	-6.03	-4.09	-2.48	-2.32	-1.84
Free Cash Flow per Basic Share	-364.05	-155.87	-218.04	-231.5	-131.25	-56.73	-35.14	-31.15	-27.43	-8.59	-6.05	-4.14	-2.48	-2.32	-1.84
Cash & Equivalents per Share	54	125.84	254.45	107.06	53.72	12.95	87.12	65.46	35.84	26.76	23.83	8.76	6.2	3.72	1.81
Book Value per Share	850.99	303.91	344.95	238.62	62.7	8.94	79.88	57.36	29.66	25.15	23.14	8.43	5.91	3.52	1.68
Tangible Book Value per Share	491.48	69.42	207.1	-58.13	36.55	-8.12	79.88	57.36	29.66	25.15	23.14	8.39	5.88	3.49	1.68

Lisata Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)